| Abstrakt: |
In this free webinar, gain critical insights into optimizing chemistry, manufacturing and controls (CMC) development for biologics programs and ensuring successful investigational new drug and biologics license application submissions. Attendees will learn about the fundamental misalignment between legacy contract development and manufacturing organizations (CDMO), CMC consultants and drug developers. The featured speakers will discuss the methods CDMOs can use to ease the CMC development pathway. The speakers will also share key considerations for CDMO selection to ensure a seamless integration of service provider and consultant. [ABSTRACT FROM PUBLISHER] |
